Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
850.00    34.00 (4.17%)
Bid:
844.00
Ask:
852.00
Spread: 8.00 (0.948%)
Market Cap: £391.82m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Acquisition

5 Apr 2017 07:00

RNS Number : 5869B
Porvair PLC
05 April 2017
 



For immediate release 5 April 2017

 

 

Porvair plc

 

Acquisition

 

Porvair ("the Group"), the specialist filtration and environmental technologies group, announces the acquisition of J. G. Finneran Associates, Inc. ("JGF").  JGF, based in Vineland, New Jersey, designs, manufactures and distributes specialist laboratory consumables including filters, vials, microplates, closures and ancillary products.

On 4 April 2017, Porvair acquired 100% of the issued share capital of JGF and its related freehold property from the Finneran family ("the Acquisition").

The initial consideration for the Acquisition is $8.0m, payable in cash, with a further deferred cash payment of up to a maximum of $6.0m, payable in the years ending 30 November 2018 and 2019, subject to the satisfaction of certain growth targets during the years ending 31 March 2018 and 2019. The Acquisition is expected to be earnings enhancing in its first full year of ownership.

The Board sees a good fit between JGF and Porvair's already established life science and biotechnology activities. JGF brings manufacturing capabilities and strong US distribution to the Group. Together the businesses have a broad product offering for chromatography, sample preparation and environmental laboratories. Opportunities exist for combining manufacturing and marketing activities. 

The Board is pleased to welcome the Finneran family and JGF staff to the Porvair Group.

 

For further information, please contact:

Porvair plc

01553 765 500

Ben Stocks, Chief Executive

Chris Tyler, Group Finance Director

Buchanan Communications

0207 466 5000

Charles Ryland / Stephanie Watson

 

Notes to editors

 

Porvair plc

Porvair is a group of specialist filtration and environmental technology businesses. Its products are used in a range of niche filtration markets, and are derived from its expertise in the design and manufacture of filtration systems using ceramic, metal, plastic and carbon media. Its Seal Analytical business is a market leader in the manufacture of laboratory based water analysis equipment.

 

This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation (EU) No. 596/2014

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQOKQDBABKDKQK
Date   Source Headline
7th Mar 20169:01 amRNSHolding(s) in Company
7th Mar 20169:00 amRNSHolding(s) in Company
1st Feb 201611:38 amRNSDirector/PDMR Shareholding
25th Jan 20167:00 amRNSFull Year Results
7th Dec 20157:00 amRNSPre-close trading update and acquisition
17th Sep 20154:15 pmRNSDirector/PDMR Shareholding
15th Sep 20157:00 amRNSTrading Update
12th Aug 20151:15 pmRNSHolding(s) in Company
12th Aug 20151:11 pmRNSHolding(s) in Company
10th Jul 201512:45 pmRNSDirector/PDMR Shareholding
29th Jun 20157:00 amRNSInterim Results
23rd Jun 20155:00 pmRNSHolding(s) in Company
2nd Jun 20157:00 amRNSTrading Update
29th May 20155:31 pmRNSTotal Voting Rights
30th Apr 20157:02 amRNSDirector declaration
14th Apr 20152:55 pmRNSAGM resolutions
14th Apr 20157:00 amRNSAGM Statement and Trading Update
24th Mar 20152:25 pmRNSPosting of Accounts
11th Mar 20157:00 amRNSHolding(s) in Company
5th Feb 20157:00 amRNSHolding(s) in Company
30th Jan 20154:03 pmRNSEx-Dividend Date
27th Jan 201512:11 pmRNSDirectors' Shareholdings and Issue of Equity
26th Jan 201512:30 pmRNSDirector Declaration
26th Jan 20157:00 amRNSSignificant Contract Wins
26th Jan 20157:00 amRNSFull Year Results
4th Dec 20147:00 amRNSSignificant Contract Win
1st Dec 20147:00 amRNSPre-close trading update
5th Nov 20147:00 amRNSDirector/PDMR Shareholding
16th Sep 20147:00 amRNSInterim Management Statement
23rd Jun 20147:00 amRNSInterim Results
5th Jun 20148:50 amRNSTotal Voting Rights
3rd Jun 20147:00 amRNSTrading Update
23rd Apr 201411:39 amRNSDirector Declaration
8th Apr 20144:20 pmRNSAGM resolutions
8th Apr 20147:00 amRNSAGM Statement and IMS
25th Feb 20147:00 amRNSAppointment of Non-Executive Director
3rd Feb 201410:08 amRNSDirector/PDMR Shareholding
27th Jan 20147:00 amRNSPreliminary Results
16th Jan 20144:07 pmRNSBlocklisting Application
4th Dec 20137:00 amRNSPre-close trading update
29th Nov 20134:02 pmRNSTotal Voting Rights
26th Sep 20137:00 amRNSAcquisition and Licensing agreement
25th Sep 20134:10 pmRNSDirector/PDMR Shareholding
17th Sep 20137:00 amRNSInterim Management Statement
7th Aug 20134:32 pmRNSHolding(s) in Company
6th Aug 20137:00 amRNSContract extension
15th Jul 201311:17 amRNSHolding(s) in Company
9th Jul 20135:13 pmRNSHolding(s) in Company
28th Jun 201312:25 pmRNSHolding(s) in Company
28th Jun 201312:19 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.